Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington’s disease
Mitochondrial dysfunction is a common hallmark of neurological disorders. Here, the authors identify CHIR99021 as a potent enhancer of mitochondrial function, which improved mitochondrial phenotypes in Huntington’s disease models. CHIR99021 was shown to stabilize calpastatin, which suppressed calpai...
Guardado en:
Autores principales: | Di Hu, Xiaoyan Sun, Anniefer Magpusao, Yuriy Fedorov, Matthew Thompson, Benlian Wang, Kathleen Lundberg, Drew J. Adams, Xin Qi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c744060975464ee4847cf813f125987b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropathology official journal of the Japanese Society of Neuropathology.
Publicado: (1993) - Neuropathology and applied neurobiology
-
Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington’s disease
por: Rocio Gomez-Pastor, et al.
Publicado: (2017) -
Innovative Therapeutic Approaches for Huntington’s Disease: From Nucleic Acids to GPCR-Targeting Small Molecules
por: Hidetoshi Komatsu, et al.
Publicado: (2021) -
Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
por: Mélissanne de Wispelaere, et al.
Publicado: (2019)